TLDR:
- Dutch startups raised €576M in Q4 2023, a decrease of 5% compared to the previous year.
- The number of deals in Q4 increased by 36% compared to Q3 2023.
In Q4 2023, Dutch startups raised €576 million in investments, a decrease of 5% compared to the previous year. However, the number of deals increased by 36% compared to Q3 2023. Biotech companies dominated the top 10 deals of the quarter, with VectorY Therapeutics securing €129 million. Fintech companies also saw increased investment. 2023 marked a 27% decrease in funding for Dutch startups and scale-ups compared to the previous year, but this decline is less noticeable than the global average. Several large venture capital funds emerged in the life sciences sector over the past year, including Forbion Ventures Fund VI and Gilde Healthcare Venture & Growth VI. There are still funds with available capital to invest, and with expectations for steady growth in startup investments, 2024 looks promising for Dutch startups.
